A carregar...
EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest
Despite the fact that temozolomide (TMZ) has been widely accepted as the key chemotherapeutic agent to prolong the survival of patients with glioblastoma, failure and recurrence cases can still be observed in clinics. Glioma stem-like cells (GSCs) are thought to be responsible for the drug resistanc...
Na minha lista:
| Publicado no: | Cell Cycle |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5499844/ https://ncbi.nlm.nih.gov/pubmed/28436750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2017.1315492 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|